Jeff Yass’s OrthoPediatrics KIDS Stock Holding History

Jeff Yass’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,543	Closed	-$231K	–	13997
2026 Q1	$231K	Buy	+14,543	New	+$254K	﹤0.01%	11429
2025 Q3	–	Sell	-22,059	Closed	-$474K	–	13190
2025 Q2	$474K	Sell	22,059 -4,777	-18%	-$103K	﹤0.01%	9296
2025 Q1	$661K	Buy	+26,836	New	+$663K	﹤0.01%	8285
2024 Q1	–	Sell	-8,523	Closed	-$238K	–	12780
2023 Q4	$277K	Buy	+8,523	New	+$247K	﹤0.01%	9987
2023 Q3	–	Sell	-5,141	Closed	-$225K	–	12496
2023 Q2	$225K	Sell	5,141 -129,627	-96%	-$5.98M	﹤0.01%	10030
2023 Q1	$5.97M	Buy	134,768 +59,148	+78%	+$2.61M	﹤0.01%	3183
2022 Q4	$3M	Buy	75,620 +71,070	+1,562%	+$2.96M	﹤0.01%	4022
2022 Q3	$210K	Sell	4,550 -28,903	-86%	-$1.42M	﹤0.01%	10716
2022 Q2	$1.44M	Buy	+33,453	New	+$1.53M	﹤0.01%	5637
2020 Q1	–	Sell	-19,721	Closed	-$884K	–	10578
2019 Q4	$927K	Buy	+19,721	New	+$764K	﹤0.01%	5668

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Jeff Yass's KIDS Position: Q2 2026 in Review

Jeff Yass sold out of OrthoPediatrics (KIDS) in Q2 2026, closing a stake of 14,543 shares — an estimated $231K sold.

Jeff Yass first reported a position in KIDS in Q4 2019 and held it in 10 quarters. The position peaked at $5.97M in Q1 2023. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

Jeff Yass reported no remaining OrthoPediatrics position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 14,543 OrthoPediatrics shares in Q2 2026, an estimated $231K.
Jeff Yass first reported a position in OrthoPediatrics in Q4 2019 and held it in 10 quarters.
Jeff Yass's OrthoPediatrics position peaked at $5.97M in Q1 2023.
119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.